EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

COVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020–2021)

Diana Ponce iD, Matthew Westercamp iD, Giselle Soto iD, Fernanda C Lessa, Perrine Marcenac iD, Candice Romero, María Silva, Rachel Smith iD, Garret Mahon, Alejandro Llanos-Cuentas, Eduardo Matos iD, Michael Prouty iD und 2 weitere

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf343 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Diana Ponce und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vysnova Partners, Inc., Alexandria, Virginia, USA assigned to Clinical Trials Unit, NAMRU SOUTH. Hauptthemen laut MEDLINE: COVID-19, Health Personnel. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CDC Interagency Agreements.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The coronavirus disease 2019 (COVID-19) pandemic placed significant pressure on healthcare workers (HCWs) globally, exposing them to high risks of infection and psychological stress. This study assessed dynamic risks and protective factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among HCWs in Lima, Peru.

Methods

We conducted the Peru Healthcare Worker COVID Cohort (PHCWCC), a prospective cohort study during the pre-COVID-19 vaccination period (August 2020–May 2021) and the post-vaccination period (August 2021–May 2022). Data included weekly nasal swabs for SARS-CoV-2 testing, reports on exposures, symptoms, perceived risks, and vaccination status. Incidence and factors associated with SARS-CoV-2 positivity were analyzed.

Results

Among 1369 HCWs, the infection rate increased from 1.15 (95% confidence interval [CI]: .90–1.14) to 1.71 (95% CI: 1.41–2.05) per 1000 HCW-days between the pre- and post-vaccination phases (P = .01). Despite 97% receiving the primary vaccine series and 75% a booster, perceived high infection risk rose from 26% to 35% (P < .001). Close contact with infected colleagues remained a consistent risk factor (odds ratio [OR] = 2.74, 95% CI: 1.85–4.05; P < .001). In the second phase, direct patient contact (OR = 1.92, 95% CI: 1.20–3.08; P = .006) and patient care environments (OR = 2.14, 95% CI: 1.35–3.40; P = .001) were linked to higher infection risk. Perceived infection risk was inversely associated with positivity (OR = 0.76, 95% CI: 0.63–0.91; P = .003).

Conclusions

Evolving infection risks highlight the need for sustained infection prevention, including during non-patient care activities. Fostering risk awareness may reduce infection rates and strengthen healthcare system resilience.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Health PersonnelHumansPeruMaleFemaleAdultProspective StudiesLongitudinal StudiesMiddle AgedSARS-CoV-2Risk FactorsOccupational ExposureCOVID-19 VaccinesIncidence

Stichwörter der Autor:innen

COVID-19healthcare workersoccupational exposureprotective measuresrisk perception

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Vysnova Partners, Inc., Alexandria, Virginia, USA assigned to Clinical Trials Unit, NAMRU SOUTH.
  • Division of Healthcare Quality Promotion, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Clinical Trials Unit, U.S. Naval Medical Unit Research SOUTH (NAMRU SOUTH), Lima, Peru.
  • Influenza Division, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Infectious Diseases and Tropical Medicine Department, Cayetano Heredia Hospital, Lima, Peru.
  • Infectious Diseases Department, Arzobispo Loayza National Hospital, Lima, Peru.

ORCID-Profile: Diana Ponce, Matthew Westercamp, Giselle Soto, Perrine Marcenac, Rachel Smith, Eduardo Matos, Michael Prouty, Andres Espinosa-Bode, Joan Neyra

Förderung

  • CDC Interagency Agreements

Zitieren

APA

Ponce, D., Westercamp, M., Soto, G., Lessa, F. C., Marcenac, P., Romero, C., Silva, M., Smith, R., Mahon, G., Llanos-Cuentas, A., Matos, E., Prouty, M., Espinosa-Bode, A., & Neyra, J. (2025). COVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020–2021). Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf343

Vancouver

Ponce D, Westercamp M, Soto G, Lessa FC, Marcenac P, Romero C, et al. COVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020–2021). Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf343

BibTeX
@article{Ponce2025,
  author = {Ponce, Diana and Westercamp, Matthew and Soto, Giselle and Lessa, Fernanda C and Marcenac, Perrine and Romero, Candice and Silva, María and Smith, Rachel and Mahon, Garret and Llanos-Cuentas, Alejandro and Matos, Eduardo and Prouty, Michael and Espinosa-Bode, Andres and Neyra, Joan},
  title = {COVID-19 Exposure, Protective Measures, Symptom Assessment, and Risk Perception Among Healthcare Workers in Peru: A Longitudinal Cohort Study (2020–2021)},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf343}
}
Kostenlos starten →